Keyphrases
Peru
100%
Guaifenesin
69%
Acute Bronchiolitis
69%
Trimethoprim-sulfamethoxazole (TMP-SMX)
69%
Adverse Events
69%
Pediatric Patients
69%
Adult Patients
69%
Endocarditis
69%
Early Surgery
69%
Streptococcus Agalactiae
69%
People Living with HIV (PLHIV)
60%
Peruvian
57%
Lima
45%
National Survey
34%
Latin American Patient
34%
Helicobacter Pylori (H. pylori)
34%
Ki-67
34%
Upper Digestive Endoscopy
34%
Breast Cancer Subtypes
34%
Gastritis
34%
Private Hospitals
34%
Young Lives
34%
Patient Survival
34%
Immuno
34%
Discordant Response
34%
Antiviral Response
34%
HIV-positive
34%
Adult People
34%
Linkage to Care
34%
AIDS/HIV
34%
Median Survival
34%
Self-assessed Health
34%
HIV Treatment
34%
Pancreatic Ductal Adenocarcinoma
34%
Older Adults
34%
Hepatitis C
34%
Helicobacter Pylori Infection
34%
Laboratory Assessment
34%
Highly Active Antiretroviral Therapy (HAART)
31%
Pediatric
27%
CD4+
26%
Opportunistic Infections
26%
Odds Ratio
23%
Confidence Interval
23%
Early Diagnosis
23%
Improved Patient Outcomes
23%
São Paulo-Brazil
23%
Non-pregnant Adults
23%
Retrospective Case Series
23%
Valve Surgery
23%
Pharmacology, Toxicology and Pharmaceutical Science
Streptococcus Agalactiae
69%
Endocarditis
69%
Guaifenesin
69%
Bronchitis
69%
Cotrimoxazole
69%
Adverse Event
69%
Hepatitis C
34%
HIV
34%
Gastritis
34%
Chemotherapy
34%
Immunoglobulin
34%
Pancreas Adenocarcinoma
34%
Helicobacter Infection
34%
Helicobacter Pylori
34%
Neoplasm
23%
Opportunistic Infection
20%
Prevalence
17%
Chronic Gastritis
17%
Jejunum Ulcer
17%
Gastrointestinal Disease
17%
Pharmacovigilance
13%
Overall Survival
11%
Metastasis
11%
Cohort Study
11%
Liver Disease
7%
Mixed Infection
6%
Onset Age
6%
Medicine and Dentistry
Gastrointestinal Endoscopy
34%
HIV/AIDS
34%
Gene Linkage
34%
Human Immunodeficiency Virus
34%
Pancreas Adenocarcinoma
34%
Helicobacter Infection
34%
Proteinase Inhibitor
34%
Laboratory Assessment
34%
Hepatitis C
34%
Gastritis
23%
Neoplasm
23%
Neoadjuvant Chemotherapy
23%
Clinical Stage
23%
Helicobacter Pylori
23%
Chronic Gastritis
11%
Jejunum Ulcer
11%
Age Groups
11%
Gastrointestinal Disease
11%
Outpatient Care
11%
Radiological Finding
11%
Prevalence
11%
Medical Record
11%
Neoadjuvant Therapy
11%
Overall Survival
11%
Adjuvant Chemotherapy
11%
Retrospective Cohort Study
11%
Pancreatectomy
11%
Metastatic Carcinoma
11%
Surgery
11%
Antiretroviral Therapy
9%